All In MedTech

Device Trial Radar · NCT06868615

AVAVA MIRIA General Use

Last checked: Nov 20, 2026Latest source record: Sep 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

200

Planned (sponsor's estimate)

Start

Sep 11, 2024

Primary completion

Dec 30, 2027

Study completion Dec 30, 2027

Sponsor

Lead sponsor
AVAVA, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Mar 11, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

A general protocol to treat a variety of dermatologic conditions and collect patient feedback. Primary outcome is the collection and analysis of patient questionnaires related to the overall experience of the device treatment. Secondary outcome measures include physician and subject evaluations in regards to improvement seen in the device as well as assessment of side effects.

Conditions

  • Acne
  • Acne Scars - Mixed Atrophic and Hypertrophic
  • Scars
  • Wrinkle
  • Pigment; Lesion
  • Skin Texture Disorder

Interventions

  • AVAVADevice

    1550nm Non-Ablative Fractional Laser

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Completion of Post-Treatment Subject QuestionnaireTime frame: Immediate Post-Treatment

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • AVAVA, Inc.

    Waltham, Massachusetts · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.